Bausch Net Income Applicable To Common Shares from 2010 to 2026
| BLCO Stock | USD 17.50 0.38 2.22% |
Net Income Applicable To Common Shares | First Reported 2010-12-31 | Previous Quarter 5.4 M | Current Value 5.1 M | Quarterly Volatility 342.3 M |
Macro event markers
Review Bausch Lomb financial statements over time to add context on performance and capital structure. Track Tax Provision of 64.9 M, Interest Income of 7.3 M or Depreciation And Amortization of 343.9 M and ratios such as Price To Sales Ratio of 1.79, Dividend Yield of 0.0 or PTB Ratio of 0.66 to align performance context with Bausch Lomb Valuation and Volatility.
Bausch | Net Income Applicable To Common Shares | Build AI portfolio with Bausch Stock |
Evaluating Bausch Lomb's Net Income Applicable To Common Shares across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Bausch Lomb Corp's fundamental strength.
Latest Bausch Lomb's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Bausch Lomb Corp over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Bausch Lomb's Net Income Applicable To Common Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bausch Lomb's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Bausch Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | 404,737,059 | |
| Coefficient Of Variation | 84.57 | |
| Mean Deviation | 323,219,585 | |
| Median | 710,000,000 | |
| Standard Deviation | 342,281,865 | |
| Sample Variance | 117156.9T | |
| Range | 728M | |
| R-Value | -0.89 | |
| Mean Square Error | 26220.3T | |
| R-Squared | 0.79 | |
| Slope | -60,252,843 | |
| Total Sum of Squares | 1874510T |
Bausch Net Income Applicable To Common Shares History
About Bausch + Lomb Corp
Bausch Lomb Corporation operates as an eye health company worldwide. The company was founded in 1853 and is headquartered in Vaughan, Canada. Bausch Lomb operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 12500 people. A high-level view of Bausch Lomb emphasizes earnings durability, balance-sheet flexibility, and competitive positioning. Current metrics include P/E of 39.08, P/B of 0.96, profit margin of -7.06%. Bausch Lomb has a market cap of 6.21 B, P/E of 39.08, ROE of -5.39%. 
Gabriel Shpitalnik · Member of Macroaxis Editorial Board
Methodology
Unless otherwise specified, financial data for Bausch Lomb Corp is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Bausch (USA Stocks:BLCO) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: This report references public filings and market reference sources and institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Certain datasets may update with delay depending on source availability. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Bausch Lomb Corp may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Bausch Stock is Curated By:
Gabriel Shpitalnik · Member of Macroaxis Editorial BoardPair Trading with Bausch Lomb
Pair trading with Bausch Lomb can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Moving together with Bausch Stock
Moving against Bausch Stock
| 0.48 | BSX | Boston Scientific Corp | PairCorr |
| 0.46 | SKYI | Sky Century Investment | PairCorr |
| 0.38 | DHR | Danaher Sell-off Trend | PairCorr |
| 0.34 | CYRX | Cryoport | PairCorr |
| 0.31 | MSB | Mesabi Trust | PairCorr |
Correlation analysis helps investors find suitable substitutes for Bausch Lomb during tax-loss harvesting periods. Selling Bausch Lomb Corp at a loss and immediately repurchasing it would violate IRS wash-sale rules, so a correlated replacement asset is required to maintain portfolio.
Measuring the statistical correlation of Bausch Lomb Corp against other instruments helps investors understand portfolio diversification. A correlation near zero implies that Bausch Lomb provides genuine diversification benefits, while high positive correlations suggest redundant exposures.
Correlation analysis and pair trading evaluation for Bausch Lomb can be used to frame hedging context. The context can be applied within sectors, industries, or broader universes.More Resources for Bausch Stock Analysis
A structured review of Bausch Lomb Corp often starts with core financial statements and trend context. Financial ratios provide context for profitability, efficiency, and growth trends. Below are reports that help frame Bausch Lomb Corp Stock in context:Review Bausch Lomb Correlation against competitors for Bausch Lomb. The view adds relative comparison context. Analysis related to Bausch Lomb should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Quarterly Earnings Growth -0.89 | Earnings Share -1.04 | Revenue Per Share | Quarterly Revenue Growth 0.098 | Return On Assets |
The market value of Bausch Lomb Corp is measured differently than book value, which reflects Bausch accounting equity. Bausch Lomb's market capitalization is 6.21 B. A P/B ratio of 0.96 suggests Bausch Lomb trades near or below book value. Enterprise value stands at 10.92 B. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
Note that Bausch Lomb's intrinsic value and market price are different measures derived from different inputs. For Bausch Lomb, key inputs include a P/E ratio of 39.08, a P/B ratio of 0.96, a profit margin of -7.06%, and ROE of -5.39%. Trading price represents the transaction level agreed by market participants.